Showing results (61-70 of 85) with videos related to
Sort By:
Pageof 9
Journal of Cancer Research and Clinical Oncology|January 1, 1993
In vitro and in vivo chemosensitizing effect of cyclosporin A on an intrinsic multidrug-resistant rat colon tumourW Van de Vrie, E E Gheuens, N M Durante, et al.Seminars in Oncology|June 8, 2001
Erythrocytes and the transfer of anticancer drugs and metabolites: a possible relationship with therapeutic outcomeH Dumez, M Highley, G Guetens, et al.Journal of Chromatography. A|July 26, 2005
Sensitive and specific quantification of the anticancer agent ZD1839 (Gefitinib) in plasma by on-column focusing capillary liquid chromatography-tandem mass spectrometryG Guetens, H Prenen, G De Boeck, et al.British Journal of Cancer|February 1, 1995
Microvessel quantification in primary colorectal carcinoma: an immunohistochemical studyP B Vermeulen, D Verhoeven, H Fierens, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 9, 2005
Balloon catheter hypoxic pelvic perfusion with mitomycin C and melphalan for locally advanced tumours in the pelvic region: a phase I-II trialM G A van Ijken, B van Etten, G Guetens, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1995
Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomasP B Vermeulen, D Verhoeven, G Hubens, et al.British Journal of Cancer|February 12, 1998
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumoursL C Pronk, D Schrijvers, J H Schellens, et al.Seminars in Oncology|April 16, 1998
Docetaxel and ifosfamide in patients with advanced solid tumors: results of a phase I studyL C Pronk, D Schrijvers, J H Schellens, et al.Journal of Mass Spectrometry : JMS|November 28, 1997
Gas chromatographic/mass spectrometric assay for profiling the enantiomers of 3,4-methylenedioxymethamphetamine and its chiral metabolites using positive chemical ionization ion trap mass spectrometryD de Boer, L P Tan, P Gorter, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumoursH Dumez, A Awada, M Piccart, et al.Pageof 9